| Autor: |
Kiss TL; Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Canada., Lipton JH, Bergsagel DE, Meharchand JM, Jamal N, Minden MD, Messner HA |
| Jazyk: |
angličtina |
| Zdroj: |
Leukemia & lymphoma [Leuk Lymphoma] 1994 Jul; Vol. 14 (3-4), pp. 335-40. |
| DOI: |
10.3109/10428199409049687 |
| Abstrakt: |
Interleukin 6 (IL6) plasma levels were measured in 63 patients with multiple myeloma and 8 individuals with benign monoclonal gammopathy. 15 of these 71 samples showed by an enzyme linked immunosorbent assay (ELISA) detectable levels that ranged from 5 to 107 pg of IL6/ml. The IL6 levels of patients with multiple myeloma did not differ significantly from those of normal individuals (N = 25, range 5-27 pg IL6/ml) (Student's t-test, p = 0.295). The samples were negative for IL4; 3 were found positive for IL1 beta. A correlation between IL6, IL4 and IL1 beta levels and disease status was not observed for this group of patients. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
